• Home
  • Industry
  • Exemption
  • Special Access Medical Device

Special Access Medical Device

 

Please be informed that our email sa [DOT] cm [AT] mdb [DOT] gov [DOT] my will permanantely closed on 1st May 2022.

For future correspondance please submit to sa [DOT] cm [AT] mda [DOT] gov [DOT] my .

 

Latest updates:

1.       Please be informed that with effect from 1st July 2022, Issuance of Special Access Notification Letter for COVID-19 Test Kits (Professional Use) that have obtained the decision of Recommended for Use (RFU) are subject to the followings:   

  1. An applicant who wishes to apply this notification is required to provide a proof of registration application that has been submitted via MeDC@St system.
  2. The Special Access Letter issued is valid until 28th February 2023 and multiple shipments are allowed for the importation / supply of the COVID-19 Test Kits to the permitted healthcare facility.

Note: Subsequent application is only required for addition of a new healthcare facility.

    c. The applicant is required to submit the following requirements on the 15th of every month:

  1.  A monthly report that contains information on Notification Special Access ID, Delivery Date and Quantity Delivered.
  2. A copy of Delivery Order (s).

 

2.       Latest Policy on Registration of COVID-19 Test (Professional Use Kit and Self-Test)

  1.  Please click here 

 

3.       Guideline for Registration of COVID-19 IVD Test Kits:

  1. Please click here

 

Additional Information on COVID-19 Test Kit Special Access Notification

 CN

 

Instant guide to Covid-19 Test Kit Special Access Notification

No.

New Application

1.     

*Special Access Form - Route B

*Remark : Information on Section B : Medical Practitioner Details  is not necessary

2.     

List of supporting documents:

     i.       Copy of Legal Manufacturer’s QMS ISO 13485 Certificate

    ii.       Pre-market Approval/Registration Certificate/Emergency Use Authorization

   iii.       Instruction for Use (IFU)

  iv.       Full Performance Report/Clinical Study Report provide by Legal Manufacturer

   v.       Copy of Establishment Licence of Applicant (for company)

  vi.       Letter of Authorization (LoA) from the Legal Manufacturer

 vii.       Information on Batch Lot Number

Remark: Only completed application will be tabled at The Expert Committee Meeting

3.     

MDA will notify the applicant of the decision made by the MDA Expert IVD Evaluation Committee.

4.     

For application which has obtained the decision of  “Recommended for Evaluation”, a letter for the purposes of importation and evaluation by recognised local laboratory will be issued.

The applicant will liaise with the respective laboratory for sending test kit to be evaluated.

5.     

For application which has obtained the decision of  “Recommended to be Used”,  the applicant is required to submit:

i.       Information on Section B : Medical Practitioner Details 

ii.      Purchase Order (as an evidence that the unregistered test kit is requested by the Healthcare Practitioner)

6.     

After requirements set out in paragraph 5 have been fulfilled, invoice will be issued.

*Remark: The Special Access Fees is for RM300.00 per healthcare facility

7.     

*Payment needs to be made by the applicant before issuance of Special Access Letter.

*Remark: Payment can be made via Bank Draft or Telegraphic Transfer/Direct Bank Transfer

 

Subsequent Application

(Addition of Healthcare Facility/Test Kit)

1.     

Special Access Form - Route B

*Remark : Information on Section B is necessary

2.     

Supporting document: Purchase Order (PO)

3.     

After requirements set out in paragraph 1 and 2 have been fulfilled, invoice will be issued.

*Remark: The Special Access Fees is for RM300.00 per healthcare facility

4.     

*Payment needs to be made by the applicant before issuance of Special Access Letter.

*Remark:

a.     Payment can be made via Bank Draft or Telegraphic Transfer/Direct Bank Transfer.

b.     No payment is required for an extension of supply/import of the unregistered medical device to the existing healthcare facility (that has previously obtained a Special Access Letter). 


Last updated June 23rd, 2022

Print

  Medical Device Authority (MDA),
Ministry of Health Malaysia,
Level 6, Prima 9, Prima Avenue II,
Block 3547, Persiaran APEC,
63000 Cyberjaya, Selangor, MALAYSIA

  +603 - 8230 0300
  +603 - 8230 0200 
  mdb [AT] mda [DOT] gov [DOT] my

Today 2533 Yesterday 7589 Week 33101 Month 15685 Visitor Counter: 113920639

  • Last Modified: 30 November 2022.
facebooktwitterinstagramyoutube
Copyright © 2022 Medical Device Authority
Ministry of Health Malaysia
Best view with Firefox 64 and above, minimum resolution 1366x768